Background The impact of adjuvant radiotherapy (RT) on atypical meningioma (AM)
underwent a gross total resection (GTR) remains unclear, showing conflicting results from …

Objectives This study investigated whether radiomic features can improve the prediction
accuracy for tumor recurrence over clinicopathological features and if these features can be …

Somatostatin receptor (SSTR)-targeted peptide receptor radionuclide therapy (PRRT)
represents a promising approach for treatment-refractory meningiomas progressing after …

Purpose WHO grade II meningiomas behave aggressively, with recurrence rates as high as
60%. Although complete resection in low-grade meningiomas is associated with a relatively …

Background Meningioma is the most common primary tumor of the central nervous system.
Preoperative diagnosis of high-grade meningioma is helpful for the selection of treatment …

Meningioma is the most common primary tumor of the central nervous system (CNS).
Individualized treatment strategies should be formulated for the patients according to the …

Background Atypical meningiomas are characterized by a high rate of recurrence and
shorter overall survival (OS) compared with grade I meningioma. Predictive parameters for …

Background Accounting for 15–20% of all meningiomas, WHO grade II meningiomas
represent an intermediate group regarding risk of tumor recurrence. However, even within …

Aim: This study aimed to investigate the relationship between clinicopathological
characteristics of atypical meningiomas (AM) and its post-operative recurrence. Materials …

Meningiomas and their WHO histological diagnostic criteria is complex, especially for grade
2 tumors presenting a interobserver discordance as high as 12.2%. The 2016 edition of the …